Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neoplasms, Plasma Cell × fludarabine phosphate × Clear all

Phase

Status

Sponsor Class

OTHER 38 NIH 6 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Neoplasms, Plasma Cell 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Burkitt Lymphoma 1

Interventions

fludarabine phosphate 1 fludarabine 1 daratumumab 1 carfilzomib 1 Lenalidomide 1 Dexamethasone 1 Cyclophosphamide 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05528887 2022-09-06

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase 1 Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡